Production of peptides in plants as viral coat protein fusions

Details Production of peptides in plants as viral coat protein fusions Production of peptides in plants as viral coat protein fusions

2001-01-05

2003-12-09

Fox, David T. (Department: 1638)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

C435S070100, C435S235100, C435S320100, C435S419000, C435S468000, C536S023400, C536S023500, C536S023720, C800S278000, C800S288000

Reexamination Certificate

active

06660500

ABSTRACT:

FIELD OF THE INVENTION
The present invention relates to the field of genetically engineered peptide production in plants, more specifically, the invention relates to the use of tobamovirus vectors to express fusion proteins.
BACKGROUND OF THE INVENTION
Peptides are a diverse class of molecules having a variety of important chemical and biological properties. Some examples include; hormones, cytokines, immunoregulators, peptide-based enzyme inhibitors, vaccine antigens, adhesions, receptor binding domains, enzyme inhibitors and the like. The cost of chemical synthesis limits the potential applications of synthetic peptides for many useful purposes such as large scale therapeutic drug or vaccine synthesis. There is a need for inexpensive and rapid synthesis of milligram and larger quantities of naturally-occurring polypeptides. Towards this goal many animal and bacterial viruses have been successfully used as peptide carriers.
The safe and inexpensive culture of plants provides an improved alternative host for the cost-effective production of such peptides. During the last decade, considerable progress has been made in expressing foreign genes in plants. Foreign proteins are now routinely produced in many plant species for modification of the plant or for production of proteins for use after extraction. Animal proteins have been effectively produced in plants (reviewed in Krebbers et al., 1992).
Vectors for the genetic manipulation of plants have been derived from several naturally occurring plant viruses, including TMV (tobacco mosaic virus). TMV is the type member of the tobamovirus group. TMV has straight tubular virions of approximately 300×18 nm with a 4 nm-diameter hollow canal, consisting of approximately 2000 units of a single capsid protein wound helically around a single RNA molecule. Virion particles are 95% protein and 5% RNA by weight. The genome of TMV is composed of a single-stranded RNA of 6395 nucleotides containing five large ORFs. Expression of each gene is regulated independently. The virion RNA serves as the messenger RNA (mRNA) for the 5′ genes, encoding the 126 kDa replicase subunit and the overlapping 183 kDa replicase subunit that is produced by read through of an amber stop codon approximately 5% of the time. Expression of the internal genes is controlled by different promoters on the minus-sense RNA that direct synthesis of 3′-coterminal subgenomic mRNAs which are produced during replication (FIG.
1
). A detailed description of tobamovirus gene expression and life cycle can be found, among other places, in Dawson and Lehto,
Advances in Virus Research
38:307-342 (1991). It is of interest to provide new and improved vectors for the genetic manipulation of plants.
For production of specific proteins, transient expression of foreign genes in plants using virus-based vectors has several advantages. Products of plant viruses are among the highest produced proteins in plants. Often a viral gene product is the major protein produced in plant cells during virus replication. Many viruses are able to quickly move from an initial infection site to almost all cells of the plant. Because of these reasons, plant viruses have been developed into efficient transient expression vectors for foreign genes in plants. Viruses of multicellular plants are relatively small, probably due to the size limitation in the pathways that allow viruses to move to adjacent cells in the systemic infection of entire plants. Most plant viruses have single-stranded RNA genomes of less than 10 kb. Genetically altered plant viruses provide one efficient means of transfecting plants with genes coding for peptide carrier fusions.
SUMMARY OF THE INVENTION
The present invention provides recombinant plant viruses that express fusion proteins that are formed by fusions between a plant viral coat protein and protein of interest. By infecting plant cells with the recombinant plant viruses of the invention, relatively large quantities of the protein of interest may be produced in the form of a fusion protein. The fusion protein encoded by the recombinant plant virus may have any of a variety of forms. The protein of interest may be fused to the amino terminus of the viral coat protein or the protein of interest may be fused to the carboxyl terminus of the viral coat protein. In other embodiments of the invention, the protein of interest may be fused internally to a coat protein. The viral coat fusion protein may have one or more properties of the protein of interest. The recombinant coat fusion protein may be used as an antigen for antibody development or to induce a protective immune response.
Another aspect of the invention is to provide polynucleotides encoding the genomes of the subject recombinant plant viruses. Another aspect of the invention is to provide the coat fusion proteins encoded by the subject recombinant plant viruses. Yet another embodiment of the invention is to provide plant cells that have been infected by the recombinant plant viruses of the invention.


REFERENCES:
patent: 4885248 (1989-12-01), Ahlquist
patent: 5173410 (1992-12-01), Ahlquist
patent: 5466788 (1995-11-01), Ahlquist
patent: 5500360 (1996-03-01), Ahlquist et al.
patent: 5602242 (1997-02-01), Ahlquist et al.
patent: 5627060 (1997-05-01), Ahlquist et al.
patent: 5633447 (1997-05-01), Ahlquist et al.
patent: 5670353 (1997-09-01), Ahlquist et al.
patent: 5929304 (1999-07-01), Radin et al.
patent: 5977438 (1999-11-01), Turpen et al.
patent: 6232099 (2001-05-01), Chapman et al.
patent: B7 195 191 (1992-03-01), None
patent: 067553 (1984-04-01), None
patent: 174759 (1986-03-01), None
patent: 194809 (1986-09-01), None
patent: AO 425 004 (1991-05-01), None
patent: AO 479 180 (1992-04-01), None
patent: 0 672 754 (1993-03-01), None
patent: AO 573 767 (1993-12-01), None
patent: 278667 (1994-07-01), None
patent: 61/158443 (1986-07-01), None
patent: 63-14693 (1988-01-01), None
patent: 63/200789 (1988-08-01), None
patent: WOA89 08145 (1989-09-01), None
patent: WOA90 12107 (1990-10-01), None
patent: WO 91/15587 (1991-04-01), None
patent: WOA91 13994 (1991-09-01), None
patent: WO 92/18618 (1992-10-01), None
patent: WO 93/03161 (1993-02-01), None
patent: WO 93/JP408 (1993-10-01), None
patent: WO 95/21248 (1995-02-01), None
patent: WO 9602649 (1996-02-01), None
patent: WO 96/12027 (1996-04-01), None
Dawson et al. Phytopathology 78(6):783-789, 1988.*
Murray et al. (1996) “Production of Recombinant Human Glucocerebrosidase in Plants” FASEB Journal, vol. 10, No. 6, p. A1126; abstract.
Coppola et al. (1994) “Characterization of glycosylated and catalytically active recombinant human alpha-galactosidase A using a baculovirus vector” Gene, vol. 144, No. 2, pp. 197-203.
Ahlquist et al., “Viral Vectors,” Cold Spring Harbor Laboratory, New York, 183-189 (1988).
Ahlquist and Pacha,Physiol. Plant.79:163-167 (1990).
Barton et al.,Plant Physiol.85:1103-1109 (1987).
Bruening, G., “Comovirus group, C.M.I./A.A.B. Descriptions of plant viruses,” No. 199. Wm. Culross and Son Ltd., Coupar Angus, Perthshire, Scotland. (1978).
Butler and Mayo, “Molecular architecture and assembly of tobacco mosaic virus particles,”The molecular biology of the positive strand RNA Viruses,Academic Press, London:237-257 (1987).
Cassidy and Nelson,Phytopathology80:1037 (1990).
Chapman et al.,Plant Journal2:549 (1992).
Charoenvit et al., “Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence,”Science251:668-671 (1991).
Charoenvit et al., “Monoclonal, but not polyclonal, antibodies protect againstPlasmodium yoeliisporozoites,”J. Immunol.146:1020-1025 (1991).
Citovsky and Zambryski,BioEssays13:373-379 (1991).
Culver et al., in press,Virology.
Dawson and Hilf,Ann. Rev. Plant Physiol. Plant Mol. Biol.43:527-555 (1992).
Dawson et al., “cDNA cloning of the complete genome of tobacco mosaic virus and production of infectious transcripts,”Proc. Nat. Acad. Sci. USA83:1832-1836 (1986).
Dawson et al., “Modifications of the tobacco mosaic virus coat protein gene affecting replication, movement, and symptomatology,”Phytopathol.78

Affiliated with

Also associated with

Rating

Production of peptides in plants as viral coat protein fusions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Production of peptides in plants as viral coat protein fusions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Production of peptides in plants as viral coat protein fusions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3097055